Cite
HARVARD Citation
Theilmann, W. et al. (2020). Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex. Neuropharmacology. p. . [Online].